Gregg Gilbert

Stock Analyst at Truist Securities

(2.25)
# 2,549
Out of 5,182 analysts
91
Total ratings
53.7%
Success rate
5.38%
Average return

Stocks Rated by Gregg Gilbert

DHT Holdings
Feb 16, 2024
Maintains: Buy
Price Target: $14$17
Current: $18.34
Upside: -7.31%
Collegium Pharmaceutical
Jan 4, 2024
Maintains: Buy
Price Target: $31$37
Current: $32.78
Upside: +12.87%
Bristol-Myers Squibb Company
Sep 15, 2023
Reiterates: Buy
Price Target: $84
Current: $57.78
Upside: +45.38%
Eli Lilly and Company
Jul 20, 2023
Maintains: Buy
Price Target: $430$525
Current: $868.27
Upside: -39.53%
Evolus
Mar 4, 2022
Maintains: Buy
Price Target: $11$13
Current: $5.22
Upside: +149.04%
NovoCure
Jan 20, 2022
Upgrades: Buy
Price Target: n/a
Current: $12.48
Upside: -
Merck & Co.
Jun 7, 2021
Maintains: Buy
Price Target: $96$93
Current: $110.23
Upside: -15.63%
Arcutis Biotherapeutics
Feb 2, 2021
Maintains: Buy
Price Target: $38$48
Current: $23.42
Upside: +104.95%
Coherus Oncology
Apr 17, 2020
Initiates: Buy
Price Target: $26
Current: $1.84
Upside: +1,313.04%
Matinas BioPharma Holdings
Jan 24, 2020
Initiates: Buy
Price Target: $150
Current: $0.61
Upside: +24,490.16%
Downgrades: Hold
Price Target: $93$78
Current: $11.49
Upside: +578.85%
Maintains: Hold
Price Target: $76$78
Current: $117.87
Upside: -33.83%
Maintains: Hold
Price Target: $20$18
Current: $31.26
Upside: -42.42%
Downgrades: Sell
Price Target: n/a
Current: $241.79
Upside: -
Maintains: Buy
Price Target: $178$175
Current: $201.22
Upside: -13.03%
Maintains: Hold
Price Target: $65$66
Current: $197.38
Upside: -66.56%